A Day Up For NeuBase Therapeutics, Inc.

Wed, Nov 20, 2019 at 05:30 PM
A Day Up For NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc. (NBSE:NASDAQ) rocketted today at $6.32, representing a gain of 25.1%. The stock featured on our News Catalysts scanner on Tue 12 Nov 19 at 10:10 AM. From Wed 30 Oct 19, the stock recorded 42.86% Up Days and 53.33% Green Days

The share price of the company has been moving sideways in recent weeks.

About NeuBase Therapeutics, Inc. (NBSE:NASDAQ)

Ohr Pharmaceutical Inc is a US-based pharmaceutical company which focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. The lead product of the company is topical Squalamine is a novel therapeutic product which provides non-invasive therapy to improve visual outcomes. Its product pipeline includes SQUALAMINE LACTATE OPHTHALMIC SOLUTION 0.2%, SKS sustained release ocular drug delivery platform technology, Animal Model for Dry-AMD, and Non-Ophthalmology Assets.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.